New Results
Ruxolitinib partially reverses functional NK cell deficiency in patients with STAT1 gain-of-function mutations
Alexander Vargas-Hernandez, Emily M. Mace, Ofer Zimmerman, Christa S. Zerbe, Alexandra F. Freeman, Sergio Rosenzweig, Jennifer W. Leiding, Troy Torgerson, Matthew C. Altman, Edith Schussler, Charlotte Cunningham-Rundles, Ivan K. Chinn, Imelda C. Hanson, Nicholas L. Rider, Steven M. Holland, Jordan S. Orange, Lisa R. Forbes
doi: https://doi.org/10.1101/157271
Alexander Vargas-Hernandez
aDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA
bTexas Children’s Hospital, Center for Human Immunobiology, Department of Allergy, Immunology and Rheumatology, Houston, TX, USA.
PhDEmily M. Mace
aDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA
bTexas Children’s Hospital, Center for Human Immunobiology, Department of Allergy, Immunology and Rheumatology, Houston, TX, USA.
PhDOfer Zimmerman
cNIAID and National Institutes of Health, Bethesda, MD, USA.
MDChrista S. Zerbe
cNIAID and National Institutes of Health, Bethesda, MD, USA.
dClinical Center, National Institutes of Health, Bethesda, MD, USA.
MDAlexandra F. Freeman
cNIAID and National Institutes of Health, Bethesda, MD, USA.
dClinical Center, National Institutes of Health, Bethesda, MD, USA.
MDSergio Rosenzweig
cNIAID and National Institutes of Health, Bethesda, MD, USA.
dClinical Center, National Institutes of Health, Bethesda, MD, USA.
MD, PhDJennifer W. Leiding
eDivision of Allergy and Immunology, Department of Pediatrics. University of South Florida at Johns Hopkins-All Children’s Hospital, St. Petersburg, FL, USA.
MDTroy Torgerson
fCenter for Allergy and Inflammation. University of Washington, Seattle, WA, USA.
MD, PhDMatthew C. Altman
fCenter for Allergy and Inflammation. University of Washington, Seattle, WA, USA.
Edith Schussler
gDivision of Allergy and Immunology and The Immunology Institute. Icahn School of Medicine at Mount Sinai. New York, NY, USA.
hDepartment of Medicine and Pediatrics. The Immunology Institute. Icahn School of Medicine at Mount Sinai. New York, NY, USA.
MDCharlotte Cunningham-Rundles
gDivision of Allergy and Immunology and The Immunology Institute. Icahn School of Medicine at Mount Sinai. New York, NY, USA.
hDepartment of Medicine and Pediatrics. The Immunology Institute. Icahn School of Medicine at Mount Sinai. New York, NY, USA.
MDIvan K. Chinn
aDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA
bTexas Children’s Hospital, Center for Human Immunobiology, Department of Allergy, Immunology and Rheumatology, Houston, TX, USA.
MDImelda C. Hanson
aDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA
MDNicholas L. Rider
aDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA
bTexas Children’s Hospital, Center for Human Immunobiology, Department of Allergy, Immunology and Rheumatology, Houston, TX, USA.
MDSteven M. Holland
cNIAID and National Institutes of Health, Bethesda, MD, USA.
dClinical Center, National Institutes of Health, Bethesda, MD, USA.
MDJordan S. Orange
aDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA
bTexas Children’s Hospital, Center for Human Immunobiology, Department of Allergy, Immunology and Rheumatology, Houston, TX, USA.
MD, PhDLisa R. Forbes
aDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA
bTexas Children’s Hospital, Center for Human Immunobiology, Department of Allergy, Immunology and Rheumatology, Houston, TX, USA.
MDArticle usage
Posted June 28, 2017.
Ruxolitinib partially reverses functional NK cell deficiency in patients with STAT1 gain-of-function mutations
Alexander Vargas-Hernandez, Emily M. Mace, Ofer Zimmerman, Christa S. Zerbe, Alexandra F. Freeman, Sergio Rosenzweig, Jennifer W. Leiding, Troy Torgerson, Matthew C. Altman, Edith Schussler, Charlotte Cunningham-Rundles, Ivan K. Chinn, Imelda C. Hanson, Nicholas L. Rider, Steven M. Holland, Jordan S. Orange, Lisa R. Forbes
bioRxiv 157271; doi: https://doi.org/10.1101/157271
Ruxolitinib partially reverses functional NK cell deficiency in patients with STAT1 gain-of-function mutations
Alexander Vargas-Hernandez, Emily M. Mace, Ofer Zimmerman, Christa S. Zerbe, Alexandra F. Freeman, Sergio Rosenzweig, Jennifer W. Leiding, Troy Torgerson, Matthew C. Altman, Edith Schussler, Charlotte Cunningham-Rundles, Ivan K. Chinn, Imelda C. Hanson, Nicholas L. Rider, Steven M. Holland, Jordan S. Orange, Lisa R. Forbes
bioRxiv 157271; doi: https://doi.org/10.1101/157271
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)